Bright Minds Biosciences (DRUG) Beginning Cash Balance (2020 - 2025)
Bright Minds Biosciences (DRUG) posted Beginning Cash Balance of $59.5 million for Q4 2025, up 1351.93% on a QoQ basis from $4.1 million in Q4 2024, and up 1351.93% year-over-year from $4.1 million in Q4 2024.
Bright Minds Biosciences (DRUG) Beginning Cash Balance (2020 - 2025) Analysis & Trends
Bright Minds Biosciences' Beginning Cash Balance history runs 6 years deep, the most recent figure standing at $59.5 million for Q4 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - |
| 10 | Bright Minds Biosciences | 498.53 Mn | 498.53 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 59.45 Mn |
| Dec 31, 2025 | 59.45 Mn |
| Dec 31, 2024 | 4.09 Mn |
| Dec 31, 2024 | 4.09 Mn |
| Dec 31, 2023 | 4.96 Mn |
| Dec 31, 2023 | 4.96 Mn |
| Dec 31, 2022 | 8.57 Mn |
| Dec 31, 2022 | 8.57 Mn |
| Dec 31, 2021 | 15.68 Mn |
| Dec 31, 2021 | 15.68 Mn |
| Dec 31, 2020 | 613,589.27 |
| Dec 31, 2020 | 613,589.27 |